TELA Bio (TELA) Free Cash Flow (2018 - 2026)

TELA Bio's Free Cash Flow history runs 9 years deep, the most recent figure standing at -$11.3 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 15.7% year-over-year to -$11.3 million in Q1 2026; TTM through Mar 2026 was -$30.2 million, a 20.07% increase from a year earlier, with the FY2025 full-year figure at -$28.7 million, up 32.68% from the prior year.
• Free Cash Flow eased to -$11.3 million in Q1 2026 per TELA's latest filing, from -$5.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$5.0 million in Q4 2025 and bottomed at -$14.6 million in Q1 2024.
• The 5-year median for Free Cash Flow is -$10.2 million (2022), against an average of -$9.7 million.
• Across the five-year window, Free Cash Flow sank 103.33% in 2022 and jumped 40.55% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$10.2 million in 2022, then slipped by 5.9% to -$10.8 million in 2023, then climbed by 22.47% to -$8.3 million in 2024, then soared by 40.55% to -$5.0 million in 2025, then tumbled by 127.55% to -$11.3 million in 2026.
• Per Business Quant, the three latest TELA Free Cash Flow figures stand at -$11.3 million (Q1 2026), -$5.0 million (Q4 2025), and -$5.9 million (Q3 2025).